These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 12537335

  • 1. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S, de Sonneville L, Licht R, Sergeant J, van Spronsen F.
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [Abstract] [Full Text] [Related]

  • 2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A, Prevor MB, Callender G, Druin DP.
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [Abstract] [Full Text] [Related]

  • 3. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L.
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R, Sullivan K, Young R, McGill J.
    Dev Neuropsychol; 2010 Oct; 35(1):57-65. PubMed ID: 20390592
    [Abstract] [Full Text] [Related]

  • 7. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S, Ghosh-Jerath S, Thompson S, Rocca A, Joy P, Kemp A, Rae C, Green K, Wilcken B, Christodoulou J.
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R, Huijbregts SC, de Sonneville LM, van der Meere JJ, Bosch AM, Hollak CE, Rubio-Gozalbo ME, Brouwers MC, Hofstede FC, de Vries MC, Janssen MC, van der Ploeg AT, Langendonk JG, van Spronsen FJ.
    Mol Genet Metab; 2013 May; 110 Suppl():S57-61. PubMed ID: 24183792
    [Abstract] [Full Text] [Related]

  • 10. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R.
    Mol Genet Metab; 2013 May; 110 Suppl():S44-8. PubMed ID: 24071437
    [Abstract] [Full Text] [Related]

  • 11. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK, Blau N.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [Abstract] [Full Text] [Related]

  • 12. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V, Kurzius L, Forbes P, Waisbren S.
    Mol Genet Metab; 2008 Dec; 95(1-2):17-20. PubMed ID: 18703366
    [Abstract] [Full Text] [Related]

  • 13. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J, Ullrich K, Pietsch M, Fünders B, Güttler F, Harms E.
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [Abstract] [Full Text] [Related]

  • 14. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM, Huijbregts SC, van Spronsen FJ, Verkerk PH, Sergeant JA, Licht R.
    Mol Genet Metab; 2010 Sep; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C, Kiener C, Meier N, Schmid P, Rauh M, Rascher W, Knerr I.
    Ann Nutr Metab; 2008 Sep; 53(2):91-5. PubMed ID: 18946205
    [Abstract] [Full Text] [Related]

  • 17. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
    Diamond A.
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct 29; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
    [Abstract] [Full Text] [Related]

  • 18. Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study.
    Burgard P, Rey F, Rupp A, Abadie V, Rey J.
    Pediatr Res; 1997 Mar 29; 41(3):368-74. PubMed ID: 9078537
    [Abstract] [Full Text] [Related]

  • 19. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A, Manfredini V, Biasi L, Treméa R, Schwartz IV, Wajner M, Vargas CR.
    Mutat Res; 2009 Mar 29; 679(1-2):13-6. PubMed ID: 19665577
    [Abstract] [Full Text] [Related]

  • 20. Executive function impairment in early-treated PKU subjects with normal mental development.
    Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G, Antonozzi I.
    J Inherit Metab Dis; 2004 Mar 29; 27(2):115-25. PubMed ID: 15159642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.